AMP-activated protein kinase inhibitors (Generian)

N/A

Report date: 2025/03/17 09:43:37
NME

Base Information

Drug NameAMP-activated protein kinase inhibitors (Generian)
Drug Alias NameAMPK inhibitors (University of Pittsburgh)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsMitochondrial DiseasesDiabetic NephropathiesRetinal Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesGenerian Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMitochondrial DiseasesDiabetic NephropathiesRetinal Diseases +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A